← Back to Clinical Trials
Recruiting NCT07379606

NCT07379606 Effects of Moderate Exercise and Cyclic Sighing on Stress, Cognition and Physiological Markers in Young Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07379606
Status Recruiting
Phase —
Sponsor Poznan University of Physical Education
Condition Stress
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-07-31
Primary Completion 2027-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Moderate-Intensity Physical Activity (PA)Breathing Training - Cyclic Sighing (CS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-07-31 with a primary completion date of 2027-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study investigates the effects of moderate physical exercise and cyclic sighing (breathing training) on stress, cognition, and physiological markers in young adults. It is a randomized cross-over trial with two interventions. Each participant will take part in two intervention sessions: 1. Moderate-intensity physical activity (PA): 15 minutes of stationary cycling at 65-75% of maximum heart rate (HRmax). 2. Breathing training (CS): 15 minutes of cyclic sighing, a technique involving inhaling, pausing briefly, taking a deeper breath, and exhaling slowly. A one-week washout period between sessions is planned to minimise carry-over effects and to ensure participants' physiological state is similar before the next session. During this week, participants will wear Polar Ignite wrist-worn devices to monitor physical activity and sleep. A total of 30 participants (you adults) will be enrolled. Measurements performed before and after each intervention include: * EEG using Emotiv EPOC Flex Gel (32-channel device): 2 minutes with eyes open, 2 minutes with eyes closed, during the interventions, and while performing cognitive test (N-back). * Heart rate variability (HRV) using the Polar H10 sensor. * SUDS - Subjective Units of Disress Scale for perceived stress. * N-back test for cognitive performance using Emotiv App. * Blood pressure (systolic and diastolic) and heart rate. * Pain threshold measured with a dolorimeter. * PANAS-SF - Positive and Negative Affect Schedule. Baseline questionnaires completed by participants the day before the study: * PSS-10 - Perceived Stress Scale (Cohen, Kamarck, Mermelstein). * MAAS - Mindful Attention Awareness Scale * Psychological well-being - short version * Mini-COPE - Coping with Stress Inventory * Sleep quality and average sleep duration * Chronotype questionnaire (morningness-eveningness) * GPAQ - Global Physical Activity Questionnaire * Pittsburgh Sleep Quality Index The study aims to understand how brief interventions like moderate exercise and breathing techniques affect stress, cognitive performance, and physiological responses in young adults.

Eligibility Criteria

Inclusion Criteria: * male or female participants, * age 18-35, * without chronic somatic diseases, * no current episode of psychiatric disorder (no active depression, mania, or psychosis), * regular sleep schedule in the week prior to the study, * not taking psychotropic drugs or medications, * non-smoker, * not working nightshifts. Exclusion Criteria: * consumption of alcohol or psychoactive substances the day before or on the day of the study, * intense physical activity less than 2 hours before the study, * consuming coffee, black tee, energy drinks less than 2 hours before the study, * contraindications to moderate-intensity physical activity on cycle ergometer (e.g., recent injuries), * contraindications to EEG (e.g., scalp skin conditions preventing proper electrode placement, hypersensitivity to conductive gels or pastes).

Contact & Investigator

Central Contact

Beata Jóźwiak

✉ b.jozwiak@awf.poznan.pl

📞 (61) 835 53 49

Principal Investigator

Ida Laudańska-Krzemińska

STUDY DIRECTOR

Poznan University of Physical Education

Frequently Asked Questions

Who can join the NCT07379606 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07379606 currently recruiting?

Yes, NCT07379606 is actively recruiting participants. Contact the research team at b.jozwiak@awf.poznan.pl for enrollment information.

Where is the NCT07379606 trial being conducted?

This trial is being conducted at Poznan, Poland.

Who is sponsoring the NCT07379606 clinical trial?

NCT07379606 is sponsored by Poznan University of Physical Education. The principal investigator is Ida Laudańska-Krzemińska at Poznan University of Physical Education. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology